Introduction
A llergic rhinitis occurs in over 500 million people around the world, and is a global health problem that causes major illness and disability. [1] [2] [3] [4] Despite the widespread prevalence, the overall health impact of allergic rhinitis may be under-appreciated. Within the pages of this supplement are the results of the allergies in Asia-Pacific survey. 5 Previous reports included the landmark "Allergies in America Survey," 6 followed by the "Pediatric Allergy in America," 7 and then the most recent report of "Allergies in Latin America Survey." 8 In the present manuscript the authors examined the burden of allergic rhinitis within the Pacific-Asia region. Similar to other parts of the world, allergic rhinitis is on the rise in the Asia-Pacific region, and it appears patients suffer from the same burden as patients in other parts of the globe. Congestion remains the most common complaint across all age groups, and there remains a clear need for more effective allergic rhinitis therapies. These troublesome symptoms have a significant impact with nearly 90% of patients reporting an effect on quality of life and one-third of patients saying this had a moderate affect when symptoms are the most severe. This caused nearly 50% of patients to miss school or work activities.
When evaluating treatment in this region it was interesting to note that approximately 10% of patients used some form of herbal therapy, whereas one in four patients had undergone subcutaneous immunotherapy, and nearly double the amount had some form of sublingual immunotherapy. Despite the value of intranasal corticosteroids, only a small percentage of patients used them. The authors report a variety of reasons for this, but cost does not appear to be a significant reason. Clearly there remains a need for better therapy to control the overall burden of this global disease.
The prevalence of allergic rhinitis was found to be ϳ10% in this region, which is very similar to that found in the US and other countries. The impact of this disease on quality of life is well recognized and the authors point out the effects on sleep and other activities. Each of these may very well be underestimated given the conservative approach taken in this review. One limitation of the review is that patients were not required to have a proven diagnosis of allergic rhinitis with positive testing for specific allergens; rather they had to have the physician diagnosis of allergic rhinitis. This may potentially include patients that have rhinitis from other causes such as vasomotor rhinitis, which may explain why weather changes were reported as a significant trigger for nasal symptoms.
We are pleased to publish this important supplement from our colleagues in the Asia-Pacific region. This is a continued example of research collaboration within our international community and demonstrates that our ongoing understanding of this disease process can flourish in all corners of the world through a commitment to science and the pledge to all of the patients we serve.
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